← Back to Clinical Trials
Recruiting NCT05863598

NCT05863598 Prevention of Eating Disorders Through Optimization of Protective Factors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05863598
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Body Dissatisfaction
Study Type INTERVENTIONAL
Enrollment 644 participants
Start Date 2023-05-15
Primary Completion 2027-07-31

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 20 Years
Study Type INTERVENTIONAL
Interventions
Enhancing protective factorsExpressive writing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 644 participants in total. It began in 2023-05-15 with a primary completion date of 2027-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of thin randomized controlled trial is to investigate the efficacy of a prevention program for reducing the incidence of eating disorders among youth (15-20). We target youth at these ages who experience a subjective sense of body dissatisfaction, and are thus at increased risk of developing an eating disorder. The prevention program is based on improving protective factors such as body appreciation, body image flexibility, intuitive eating, and acceptance. It will be compared to a credible placebo (expressive writing).

Eligibility Criteria

Inclusion Criteria: Youth and young people (15-20 years) with a subjective experience of body dissatisfaction. Exclusion Criteria: Indications of depression, or suicidality, as well as presence of an eating disorder, or other conditions that may require medical attention, or conditions that makes it impossible to complete the intervention (e.g., not being able to read and write in Swedish).

Contact & Investigator

Central Contact

Ata Ghaderi, PhD

✉ ata.ghaderi@ki.se

📞 +46 8 524 832 48

Principal Investigator

Ata Ghaderi, PhD

PRINCIPAL INVESTIGATOR

PI employed at Karolinska Institutet

Frequently Asked Questions

Who can join the NCT05863598 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Body Dissatisfaction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05863598 currently recruiting?

Yes, NCT05863598 is actively recruiting participants. Contact the research team at ata.ghaderi@ki.se for enrollment information.

Where is the NCT05863598 trial being conducted?

This trial is being conducted at Solna, Sweden.

Who is sponsoring the NCT05863598 clinical trial?

NCT05863598 is sponsored by Karolinska Institutet. The principal investigator is Ata Ghaderi, PhD at PI employed at Karolinska Institutet. The trial plans to enroll 644 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology